Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews · Stroke

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Cerebrolysin or Cerebrolysin‐like agents vs placebo

Total number of people with adverse events, · people with acute ischemic stroke

Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in total number of people with adverse events, compared with placebo (low certainty).

1 finding from 1 review

Cerebrolysin for acute ischaemic stroke 2023 · Cochrane Headline outcomes only
RR 1.03 [0.92, 1.14]
4 studies · 1607 participants
Low

TDC vs medical therapy

Secondary outcome:total serious adverse events at the end of · people with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack

TDC showed no clear difference in secondary outcome:total serious adverse events at the end of compared with medical therapy (low certainty).

1 finding from 1 review

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of… 2015 · Cochrane Headline outcomes only
RR 1.04 [0.88, 1.23]
3 studies · 2303 participants
Low